Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FQ84U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,384
Award facts
- Contract value 100% obligated
- $30,384.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,384.06 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The contract utilizes AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, as the place of performance.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across the Defense Health System. The company supplies a comprehensive portfolio of pharmaceuticals and medical commodities, including specialty medications, biologics, vaccines, and medical devices to support military healthcare operations globally. This delivery order for Dupixent, a biologic medication used in the treatment of eczema and other allergic conditions, exemplifies the company's role in providing specialized pharmaceutical products to federal healthcare systems. The award reflects AmerisourceBergen's established capability to meet federal procurement standards through competitive bidding and its position as a key supplier within the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB26FQ84U?
SPE2DB26FQ84U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FQ84U worth?
The government has obligated $30,384 on SPE2DB26FQ84U.
Is contract SPE2DB26FQ84U an order under another contract?
Yes. SPE2DB26FQ84U is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ84U competed?
The extent of competition for SPE2DB26FQ84U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award